Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Alert for Industry Pharm Necess & Ctnr For Drug/Bio
  • Print
  • Share
  • E-mail
-

Pharm Necess & Ctnr For Drug/Bio


DWPE = Detain without physical examination
Import Alert Number Import Alert Type Publish Date Import Alert Name
53-06 DWPE 05/18/2013 "Detention Without Physical Examination Of Cosmetics Containing Illegal Colors"
55-02 DWPE with Surveillance 12/14/2012 "Increased Surveillance Of Bulk Ingredients Susceptible To Contamination With Diethylene Glycol"
55-03 DWPE 08/06/2012 Detention Without Physical Examination of Different Forms of Heparin and Heparin- Related Products for CGMP Issues
55-04 DWPE 11/30/2012 DETENTION WITHOUT PHYSICAL EXAMINATION OF PHARMACEUTICAL-USE GELATIN FOR POTENTIALLY HAZARDOUS MICROBIOLOGICAL CONTAMINATION
55-05 DWPE 05/22/2013 DETENTION WITHOUT PHYSICAL EXAMINATION OF FINISHED DOSAGE DRUG PRODUCTS, ACTIVE PHARMACEUTICAL INGREDIENTS AND INACTIVE INGREDIENTS FOR POTENTIALLY HAZARDOUS MICROBIOLOGICAL CONTAMINATION
61-01 DWPE 03/18/2011 "Gerovital (KH3 - GH3, Etc.)"
61-05 DWPE 03/18/2011 "Methapyrilene and Drug Products Containing Methapyrilene"
61-06 DWPE 12/14/2012 "Detention Without Physical Examination of Skin Cap Spray, Shampoo And Cream"
62-07 DWPE 12/14/2012 "Detention Without Physical Examination of Shipments of Sygen Injectable (Bovine-Extracted GMI Monosialoganglioside)"
66-05 DWPE 12/14/2012 "Foreign Labeled Finished Dosage Parenterals"
66-10 DWPE 03/18/2011 Chinese Herbal Medicines
66-40 DWPE 05/22/2013 "Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs"
66-41 DWPE 05/23/2013 Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
66-57 DWPE 12/14/2012 "Detention Without Physical Examination Of Foreign manufactured Unapproved Prescription Drugs Promoted to Individuals in the U.S."
66-66 DWPE 12/17/2012 "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
66-75 DWPE 06/26/2012 DETENTION WITHOUT PHYSICAL EXAMINATION OF IMMUNO-AUGMENTATIVE THERAPY (IAT)
89-08 DWPE 05/24/2013 "Detention Without Physical Examination of Class III Devices Without Approved PMA's Or IDE's and Other Devices Not Equivalent or No 510k"
99-32 DWPE 05/01/2013 "DETENTION WITHOUT PHYSICAL EXAMINATION OF PRODUCTS FROM FIRMS REFUSING FDA FOREIGN ESTABLISHMENT INSPECTION"
99-34 DWPE 04/01/2013 DETENTION WITHOUT PHYSICAL EXAMINATION OF DRUGS OR MEDICAL DEVICES FROM FIRMS WITHOUT A VALID DRUG OR MEDICAL DEVICE REGISTRATION
-
-